Erythrocyte sodium-lithium countertransport and blood pressure: a genome-wide linkage study

Hypertension. 2003 Mar;41(3 Pt 2):842-6. doi: 10.1161/01.HYP.0000048703.16933.6D. Epub 2002 Dec 23.

Abstract

Increased activity of erythrocyte sodium-lithium countertransport is associated with essential hypertension. Sodium-lithium countertransport is highly heritable, but no single gene product mediating the exchange or explaining the association of increased sodium-lithium countertransport activity and hypertension has been identified. We performed a linkage study by using erythrocyte sodium-lithium countertransport as a quantitative phenotype and genome-wide markers at an average resolution of approximately 10 cM to identify quantitative trait loci explaining sodium-lithium countertransport activity. A peak LOD score of 2.83 was detected on chromosome 15q at D15S642, a marker previously shown to be linked to blood pressure. Several genes mapped to this region are possible candidates for factors affecting erythrocyte sodium-lithium countertransport and/or blood pressure. Further studies confirming the presence of a quantitative trait locus in this region and evaluating these candidate genes may help explain the association of elevated sodium-lithium countertransport and hypertension.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Biological Transport
  • Blood Pressure / genetics*
  • Chromosomes, Human, Pair 15
  • Erythrocytes / metabolism*
  • Female
  • Genetic Linkage
  • Genome, Human
  • Humans
  • Hypertension / genetics
  • Ion Transport
  • Linkage Disequilibrium
  • Lithium / metabolism*
  • Male
  • Quantitative Trait Loci*
  • Sodium / metabolism*

Substances

  • Lithium
  • Sodium